Success Metrics

Clinical Success Rate
83.3%

Based on 5 completed trials

Completion Rate
83%(5/6)
Active Trials
4(33%)
Results Posted
60%(3 trials)
Terminated
1(8%)

Phase Distribution

Ph phase_2
2
17%
Ph not_applicable
9
75%
Ph phase_3
1
8%

Phase Distribution

0

Early Stage

2

Mid Stage

1

Late Stage

Phase Distribution12 total trials
Phase 2Efficacy & side effects
2(16.7%)
Phase 3Large-scale testing
1(8.3%)
N/ANon-phased studies
9(75.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

83.3%

5 of 6 finished

Non-Completion Rate

16.7%

1 ended early

Currently Active

4

trials recruiting

Total Trials

12

all time

Status Distribution
Active(5)
Completed(5)
Terminated(1)
Other(1)

Detailed Status

Completed5
Recruiting3
unknown1
Terminated1
Not yet recruiting1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
12
Active
4
Success Rate
83.3%
Most Advanced
Phase 3

Trials by Phase

Phase 22 (16.7%)
Phase 31 (8.3%)
N/A9 (75.0%)

Trials by Status

unknown18%
terminated18%
not_yet_recruiting18%
recruiting325%
completed542%
active_not_recruiting18%

Recent Activity

Clinical Trials (12)

Drug Details

Intervention Type
PROCEDURE
Total Trials
12